Once-daily single-inhaler versus twice-daily multiple-inhaler triple therapy in patients with COPD: lung function and health status results from two replicate randomized controlled trials

被引：0
|
作者：
Gary T. Ferguson
Nicola Brown
Chris Compton
Thomas C. Corbridge
Kelly Dorais
Charles Fogarty
Catherine Harvey
Morrys C. Kaisermann
David A. Lipson
Neil Martin
Frank Sciurba
Marjorie Stiegler
Chang-Qing Zhu
David Bernstein
机构：
[1] Pulmonary Research Institute of Southeast Michigan,Perelman School of Medicine
[2] GlaxoSmithKline,Bernstein Clinical Research Center and Division of Immunology, Allergy and Rheumatology
[3] GlaxoSmithKline,undefined
[4] GlaxoSmithKline,undefined
[5] Northwestern University,undefined
[6] Feinberg School of Medicine,undefined
[7] GlaxoSmithKline,undefined
[8] Spartanburg Medical Research,undefined
[9] University of Pennsylvania,undefined
[10] University of Leicester,undefined
[11] University of Pittsburgh Medical Center,undefined
[12] University of North Carolina at Chapel Hill,undefined
[13] University of Cincinnati College of Medicine,undefined
来源：
Respiratory Research | / 21卷
关键词：
Triple therapy; COPD; Lung function; Symptoms; Long-acting β; -agonist (LABA); Long-acting muscarinic antagonist (LAMA); Inhaled corticosteroid (ICS);
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Once-daily single-inhaler versus twice-daily multiple-inhaler triple therapy in patients with COPD: lung function and health status results from two replicate randomized controlled trials
    Ferguson, Gary T.
    Brown, Nicola
    Compton, Chris
    Corbridge, Thomas C.
    Dorais, Kelly
    Fogarty, Charles
    Harvey, Catherine
    Kaisermann, Morrys C.
    Lipson, David A.
    Martin, Neil
    Sciurba, Frank
    Stiegler, Marjorie
    Zhu, Chang-Qing
    Bernstein, David
    [J]. RESPIRATORY RESEARCH, 2020, 21 (01)
  • [2] Once-Daily Single-Inhaler Versus Twice-Daily Multiple-Inhaler Triple Therapy: Two Replicate Trials in Patients with Chronic Obstructive Pulmonary Disease (COPD)
    Ferguson, G. T.
    Brown, N.
    Compton, C.
    Corbridge, T. C.
    Dorais, K.
    Fogarty, C. M.
    Harvey, C.
    Kaisermann, M. C.
    Lipson, D. A.
    Martin, N.
    Sciurba, F. C.
    Stiegler, M. A.
    Zhu, C.
    Bernstein, D.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [3] Once-daily single-inhaler versus twice-daily multiple-inhaler triple therapy: two replicate trials in patients with chronic obstructive pulmonary disease (COPD)
    Ferguson, G. T.
    Brown, N.
    Compton, C.
    Corbridge, T. C.
    Dorais, K.
    Fogarty, C.
    Harvey, C.
    Kaisermann, M. C.
    Lipson, D. A.
    Martin, N.
    Sciurba, F.
    Stiegler, M.
    Zhu, C. Q.
    Bernstein, D.
    [J]. PNEUMOLOGIE, 2021, 75 : S45 - S46
  • [4] Once-Daily Single-Inhaler Triple versus Dual Therapy in Patients with COPD
    Lipson, David A.
    Barnhart, Frank
    Brealey, Noushin
    Brooks, Jean
    Criner, Gerard J.
    Day, Nicola C.
    Dransfield, Mark T.
    Halpin, David M. G.
    Han, MeiLan K.
    Jones, C. Elaine
    Kilbride, Sally
    Lange, Peter
    Lomas, David A.
    Martinez, Fernando J.
    Singh, Dave
    Tabberer, Maggie
    Wise, Robert A.
    Pascoe, Steven J.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (18): : 1671 - 1680
  • [5] Reduced exacerbations following switch from multiple-inhaler to once-daily single-inhaler triple therapy in COPD patients in a real-world primary care setting in England
    Rothnie, K.
    Wood, R.
    Czira, A.
    Banks, V.
    Camidge, L.
    Massey, O.
    Seif, M.
    Compton, C.
    Sharma, R.
    Ismaila, A.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [6] INTREPID: Clinical Effectiveness of ONCE-Daily Single-Inhaler Fluticasone Furoate/Umeclidinium/Vilanterol Versus Multiple-Inhaler Triple Therapy in Usual Clinical Practice
    Halpin, D. M. G.
    Worsley, S.
    Afisi, I
    Astrom, J.
    Beeh, K. M.
    Brintziki, D.
    Di Boscio, V
    Kocks, J.
    Marin, J. M.
    Tabberer, M.
    Snowise, N. G.
    Compton, C.
    [J]. PNEUMOLOGIE, 2021, 75 : S42 - S43
  • [7] Intrepid: Clinical Effectiveness of Once-Daily Single-Inhaler Fluticasone Furoate/Umeclidinium/Vilanterol Versus Multiple-Inhaler Triple Therapy in Usual Clinical Practice
    Halpin, D. M.
    Worsley, S.
    Ismaila, A. S.
    Astrom, J.
    Beeh, K. M.
    Brintziki, D.
    Di Boscio, V.
    Kocks, J.
    Marin, J. M.
    Tabberer, M.
    Snowise, N. G.
    Compton, C.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [8] Cost-Effectiveness Of Once-Daily Single-Inhaler Triple Therapy In COPD: The IMPACT Trial
    Ismaila, Afisi S.
    Risebrough, Nancy
    Schroeder, Melanie
    Shah, Dhvani
    Martin, Alan
    Goodall, Emma C.
    Ndirangu, Kerigo
    Criner, Gerard
    Dransfield, Mark
    Halpin, David M. G.
    Han, MeiLan K.
    Lomas, David A.
    [J]. INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2019, 14 : 2681 - 2695
  • [9] Adherence and persistence to once-daily single-inhaler versus multiple-inhaler triple therapy among patients with chronic obstructive pulmonary disease in the USA: A real-world study
    Mannino, David
    Bogart, Michael
    Wu, Benjamin
    Germain, Guillaume
    Laliberte, Francois
    MacKnight, Sean D.
    Jung, Young
    Stiegler, Marjorie
    Duh, Mei Sheng
    [J]. RESPIRATORY MEDICINE, 2022, 197
  • [10] REDUCED HEALTH CARE RESOURCE UTILISATION AND COSTS FOLLOWING A SWITCH FROM MULTIPLE-INHALER TO ONCE-DAILY SINGLE-INHALER TRIPLE THERAPY IN COPD PATIENTS IN A REAL-WORLD PRIMARY CARE SETTING IN ENGLAND
    Rothnie, K. J.
    Wood, R. P.
    Czira, A.
    Banks, V. L.
    Cammidge, L. J.
    Massey, O. K.
    Seif, M.
    Compton, C.
    Sharma, R.
    Ismaila, A. S.
    [J]. VALUE IN HEALTH, 2022, 25 (12) : S484 - S484
12345